Center-Authored Papers

Filters: Author is van der Straten, Ariane  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
U
Baeten JM, Palanee-Phillips T, Brown ER, Schwartz K, Soto-Torres LE, Govender V, Mgodi NM, Kiweewa FM, Nair G, Mhlanga F et al..  2016.  Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women.. The New England journal of medicine. Abstract
T
Marrazzo JM, Ramjee G, Richardson BA, Gomez K, Mgodi N, Nair G, Palanee T, Nakabiito C, van der Straten A, Noguchi L et al..  2015.  Tenofovir-based preexposure prophylaxis for HIV infection among African women.. The New England journal of medicine. 372(6):509-18. Abstract
R
Noguchi LM, Richardson BA, Baeten JM, Hillier SL, Balkus JE, Chirenje MZ, Bunge K, Ramjee G, Nair G, Palanee-Phillips T et al..  2015.  Risk of HIV-1 acquisition among women who use different types of injectable progestin contraception in South Africa: a prospective cohort study.. The lancet HIV. 2(7):e279-e287. Abstract
Mensch BS, Brown ER, Liu K, Marrazzo J, Chirenje ZM, Gomez K, Piper J, Patterson K, van der Straten A.  2016.  Reporting of Adherence in the VOICE Trial: Did Disclosure of Product Nonuse Increase at the Termination Visit? AIDS and behavior. Abstract
P
Chen BA, Panther L, Marzinke MA, Hendrix CW, Hoesley CJ, van der Straten A, Husnik MJ, Soto-Torres L, Nel A, Johnson S et al..  2015.  Phase 1 Safety, Pharmacokinetics, and Pharmacodynamics of Dapivirine and Maraviroc Vaginal Rings: A Double-Blind Randomized Trial.. Journal of acquired immune deficiency syndromes (1999). 70(3):242-9. Abstract
van der Straten A, Mayo A, Brown ER, Amico RK, Cheng H, Laborde N, Marrazzo J, Torjesen K.  2015.  Perceptions and Experiences with the VOICE Adherence Strengthening Program (VASP) in the MTN-003 Trial.. AIDS and behavior. 19(5):770-83. Abstract
D
van der Straten A, Brown ER, Marrazzo JM, Chirenje MZ, Liu K, Gomez K, Marzinke MA, Piper JM, Hendrix CW.  2016.  Divergent adherence estimates with pharmacokinetic and behavioural measures in the MTN-003 (VOICE) study.. Journal of the International AIDS Society. 19(1):20642. Abstract
C
Palanee-Phillips T, Schwartz K, Brown ER, Govender V, Mgodi N, Kiweewa FM, Nair G, Mhlanga F, Siva S, Bekker L-G et al..  2015.  Characteristics of Women Enrolled into a Randomized Clinical Trial of Dapivirine Vaginal Ring for HIV-1 Prevention.. PloS one. 10(6):e0128857. Abstract
A
van der Straten A, Panther L, Laborde N, Hoesley CJ, Cheng H, Husnik MJ, Horn S, Nel A, Soto-Torres L, Chen BA.  2016.  Adherence and Acceptability of a Multidrug Vaginal Ring for HIV Prevention in a Phase I Study in the United States.. AIDS and behavior. Abstract